UBC Executive and Leadership Team

Bekki Brown, the President & Chief Executive Officer at UBC, directs the overarching strategic vision for this global biopharmaceutical services organization. Brown architects the integration of scientific expertise with advanced data analytics to ensure medical products meet rigorous safety and efficacy standards. By overseeing the alignment of clinical evidence generation with regulatory requirements, the President & Chief Executive Officer drives the company toward excellence in real-world evidence development. This leadership role involves constant collaboration with pharmaceutical partners to address complex drug commercialization challenges across international markets. Bekki Brown maintains a focus on scaling technology-driven platforms that support healthcare decision-making. Through the optimization of internal resources and the pursuit of innovation, the President & Chief Executive Officer secures the long-term market position of the organization. Brown ensures that every service offering directly supports the mission of providing meaningful data to the life sciences industry.

Steve Bell, the Chief Financial Officer & Acco Principal at UBC, manages the fiscal health and financial reporting structures of this biopharmaceutical services firm. Bell oversees capital allocation strategies that enable the company to invest in advanced data analytics and technology-driven platforms. By monitoring global financial performance, the Chief Financial Officer & Acco Principal ensures that evidence development solutions remain profitable while delivering high value to life sciences clients. This role requires close coordination with the executive team to align budgetary priorities with long-term growth objectives in the real-world evidence sector. Steve Bell maintains rigorous standards for financial compliance and transparency across all regional operations. Through the implementation of robust accounting frameworks, the Chief Financial Officer & Acco Principal supports the stability of the organization. Bell drives fiscal efficiency, allowing the company to focus on the core mission of supporting medical product safety and efficacy assessments.

Dean Reiman, the President at UBC, directs the operational execution of evidence development solutions across the global biopharmaceutical landscape. Reiman oversees the delivery of clinical and real-world evidence services, ensuring that pharmaceutical organizations receive actionable data for regulatory and payer decision-making. By managing the day-to-day operations of service teams, the President optimizes the application of scientific expertise to complex drug development challenges. This leadership role involves driving operational efficiency and maintaining high service quality standards across diverse international markets. Dean Reiman coordinates with other senior leaders to refine the service delivery model, ensuring that technology-driven platforms meet the evolving needs of the life sciences industry. Through the management of cross-functional teams, the President fosters an environment of continuous improvement. Reiman ensures that the organization remains a leader in providing evidence that informs healthcare decisions, ultimately supporting the successful commercialization of medical products worldwide.

Michael Haratz, the Senior Vice President, Chief Legal Officer at UBC, manages the legal framework and risk mitigation strategies for this global biopharmaceutical services organization. Haratz oversees all contractual obligations and regulatory compliance matters related to the generation of clinical and real-world evidence. By providing legal guidance on data privacy and intellectual property, the Senior Vice President, Chief Legal Officer ensures that the company operates within the strict parameters of international healthcare law. This role involves collaborating with the executive team to navigate the complexities of drug development and commercialization agreements. Michael Haratz maintains a focus on protecting the integrity of the data analytics and technology platforms used by the firm. Through the proactive management of legal risks, the Senior Vice President, Chief Legal Officer supports the overall stability and reputation of the organization. Haratz ensures that all business activities align with the mission of providing reliable evidence for healthcare decision-making.